{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:33:42Z","timestamp":1790645622455,"version":"4.1.0"},"reference-count":56,"publisher":"Impact Journals, LLC","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,3,21]]},"DOI":"10.18632\/oncotarget.14850","type":"journal-article","created":{"date-parts":[[2017,1,29]],"date-time":"2017-01-29T01:19:13Z","timestamp":1485652753000},"page":"18949-18967","source":"Crossref","is-referenced-by-count":54,"title":["Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance"],"prefix":"10.18632","volume":"8","author":[{"given":"Mannan","family":"Nouri","sequence":"first","affiliation":[{"name":"Vancouver Prostate Centre, Vancouver, Canada"},{"name":"Department of Urologic Sciences, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josselin","family":"Caradec","sequence":"additional","affiliation":[{"name":"Vancouver Prostate Centre, Vancouver, Canada"},{"name":"Department of Urologic Sciences, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Anne","family":"Lubik","sequence":"additional","affiliation":[{"name":"Vancouver Prostate Centre, Vancouver, Canada"},{"name":"Department of Urologic Sciences, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[{"name":"Vancouver Prostate Centre, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett G.","family":"Hollier","sequence":"additional","affiliation":[{"name":"Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep","family":"Takhar","sequence":"additional","affiliation":[{"name":"GenomeDX Biosciences, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Altimirano-Dimas","sequence":"additional","affiliation":[{"name":"Vancouver Prostate Centre, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqian","family":"Chen","sequence":"additional","affiliation":[{"name":"Drug Discovery & Biomedical Sciences, South Carolina College of Pharmacy, Columbia, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mani","family":"Roshan-Moniri","sequence":"additional","affiliation":[{"name":"Vancouver Prostate Centre, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Butler","sequence":"additional","affiliation":[{"name":"Vancouver Prostate Centre, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Lehman","sequence":"additional","affiliation":[{"name":"Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Bishop","sequence":"additional","affiliation":[{"name":"Vancouver Prostate Centre, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Truong","sequence":"additional","affiliation":[{"name":"Vancouver Prostate Centre, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Chieh","family":"Huang","sequence":"additional","affiliation":[{"name":"Vancouver Prostate Centre, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Cochrane","sequence":"additional","affiliation":[{"name":"Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cox","sequence":"additional","affiliation":[{"name":"Vancouver Prostate Centre, Vancouver, Canada"},{"name":"Department of Urologic Sciences, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Collins","sequence":"additional","affiliation":[{"name":"Vancouver Prostate Centre, Vancouver, Canada"},{"name":"Department of Urologic Sciences, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gleave","sequence":"additional","affiliation":[{"name":"Vancouver Prostate Centre, Vancouver, Canada"},{"name":"Department of Urologic Sciences, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Erho","sequence":"additional","affiliation":[{"name":"GenomeDX Biosciences, Vancouver, Canada"},{"name":"GenomeDX Biosciences, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Alshalafa","sequence":"additional","affiliation":[{"name":"GenomeDX Biosciences, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elai","family":"Davicioni","sequence":"additional","affiliation":[{"name":"GenomeDX Biosciences, Vancouver, Canada"},{"name":"GenomeDX Biosciences, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Nelson","sequence":"additional","affiliation":[{"name":"Vancouver Prostate Centre, Vancouver, Canada"},{"name":"Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl","family":"Gregory-Evans","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Jeffrey","family":"Karnes","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Klein","sequence":"additional","affiliation":[{"name":"Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Buttyan","sequence":"additional","affiliation":[{"name":"Vancouver Prostate Centre, Vancouver, Canada"},{"name":"Department of Urologic Sciences, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,1,27]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/PPO.0b013e318281197e","article-title":"The changing natural history of metastatic prostate cancer","volume":"19","author":"Hussain","year":"2013","journal-title":"Cancer J"},{"key":"2","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/onc.2014.115","article-title":"Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects","volume":"34","author":"de Bono","year":"2015","journal-title":"Oncogene"},{"key":"3","doi-asserted-by":"crossref","first-page":"T87","DOI":"10.1530\/ERC-13-0470","article-title":"Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer","volume":"21","author":"Dehm","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"4","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1158\/1078-0432.CCR-13-3309","article-title":"Aggressive variants of castration-resistant prostate cancer","volume":"20","author":"Rubin","year":"2014","journal-title":"Clin Cancer Res"},{"key":"5","first-page":"90","article-title":"Neuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failure","volume":"5","author":"Huang","year":"2015","journal-title":"Front Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1078-1439(97)00039-2","article-title":"Transdifferentiation of cultured human prostate cancer cells to a neuroendocrine cell phenotype in a hormone-depleted medium","volume":"3","author":"Buttyan","year":"1997","journal-title":"Urol Oncol"},{"key":"7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1677\/erc.1.01043","article-title":"Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells","volume":"13","author":"Lin","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1593\/neo.121550","article-title":"Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer","volume":"15","author":"Rubin","year":"2013","journal-title":"Neoplasia"},{"key":"9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/path.4047","article-title":"From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer","volume":"227","author":"Wang","year":"2012","journal-title":"J Pathol"},{"key":"10","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/nar\/gkt921","article-title":"REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer","volume":"42","author":"Collins","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"11","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4161\/cc.23721","article-title":"New insights into prostate cancer stem cells","volume":"12","author":"Tang","year":"2013","journal-title":"Cell Cycle"},{"key":"12","doi-asserted-by":"crossref","first-page":"10946","DOI":"10.1158\/0008-5472.CAN-05-2018","article-title":"Prospective identification of tumorigenic prostate cancer stem cells","volume":"65","author":"Maitland","year":"2005","journal-title":"Cancer Res"},{"key":"13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-59745-280-9_7","article-title":"Methodologies in assaying prostate cancer stem cells","volume":"568","author":"Tang","year":"2009","journal-title":"Methods Mol Biol"},{"key":"14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1755-8794-4-46","article-title":"Lineage relationship of prostate cancer cell types based on gene expression","volume":"4","author":"Liu","year":"2011","journal-title":"BMC Med Genomics"},{"key":"15","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.stem.2012.03.009","article-title":"The PSA(\u2212\/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration","volume":"10","author":"Ivanov","year":"2012","journal-title":"Cell Stem Cell"},{"key":"16","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nature09229","article-title":"Nuclear reprogramming to a pluripotent state by three approaches","volume":"465","author":"Blau","year":"2010","journal-title":"Nature"},{"key":"17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrd4253","article-title":"Tackling the cancer stem cells - what challenges do they pose?","volume":"13","author":"Weinberg","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"18","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1172\/JCI32810","article-title":"Stem cells in prostate cancer initiation and progression","volume":"117","author":"Witte","year":"2007","journal-title":"J Clin Invest"},{"key":"19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1373\/clinchem.2012.184655","article-title":"Cell plasticity and heterogeneity in cancer","volume":"59","author":"Chaffer","year":"2013","journal-title":"Clin Chem"},{"key":"20","doi-asserted-by":"crossref","first-page":"e2888","DOI":"10.1371\/journal.pone.0002888","article-title":"Generation of breast cancer stem cells through epithelial-mesenchymal transition","volume":"3","author":"Puisieux","year":"2008","journal-title":"PLoS One"},{"key":"21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.stem.2014.05.006","article-title":"Chromatin repressive complexes in stem cells, development, and cancer","volume":"14","author":"Helin","year":"2014","journal-title":"Cell Stem Cell"},{"key":"22","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3892\/ijo.2014.2529","article-title":"Functional characteristics of cancer stem cells and their role in drug resistance of prostate cancer","volume":"45","author":"Castellon","year":"2014","journal-title":"Int J Oncol"},{"key":"23","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/pros.23221","article-title":"Neuronal Trans-Differentiation in Prostate Cancer Cells","volume":"76","author":"Ayala","year":"2016","journal-title":"Prostate"},{"key":"24","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature14436","article-title":"Evolution of vertebrates as viewed from the crest","volume":"520","author":"Bronner","year":"2015","journal-title":"Nature"},{"key":"25","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1091\/mbc.e04-10-0949","article-title":"Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture","volume":"16","author":"Brinchmann","year":"2005","journal-title":"Mol Biol Cell"},{"key":"26","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1186\/bcr2560","article-title":"Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways","volume":"12","author":"Visvader","year":"2010","journal-title":"Breast Cancer Res"},{"key":"27","first-page":"119","article-title":"A robust method to derive functional neural crest cells from human pluripotent stem cells","volume":"2","author":"Conklin","year":"2013","journal-title":"Am J Stem Cells"},{"key":"28","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/nbt1365","article-title":"Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells","volume":"25","author":"Studer","year":"2007","journal-title":"Nat Biotechnol"},{"key":"29","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1002\/stem.211","article-title":"CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells","volume":"27","author":"Isacson","year":"2009","journal-title":"Stem Cells"},{"key":"30","first-page":"563","article-title":"CD133: to be or not to be, is this the real question?","volume":"5","author":"Pirozzi","year":"2013","journal-title":"Am J Transl Res"},{"key":"31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ijc.29382","article-title":"Cell-surface Vimentin: A mislocalized protein for isolating csVimentin(+) CD133(\u2212) novel stem-like hepatocellular carcinoma cells expressing EMT markers","volume":"137","author":"Li","year":"2015","journal-title":"Int J Cancer"},{"key":"32","doi-asserted-by":"crossref","first-page":"592","DOI":"10.5966\/sctm.2012-0003","article-title":"CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines","volume":"1","author":"Iezzi","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.semcancer.2012.04.008","article-title":"Epithelial to mesenchymal transition: new and old insights from the classical neural crest model","volume":"22","author":"Bronner","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature05384","article-title":"Identification and expansion of human colon-cancer-initiating cells","volume":"445","author":"De Maria","year":"2007","journal-title":"Nature"},{"key":"35","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/onc.2015.160","article-title":"Plexin-B1 signalling promotes androgen receptor translocation to the nucleus","volume":"35","author":"Masters","year":"2016","journal-title":"Oncogene"},{"key":"36","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/pros.21281","article-title":"A role for class 3 semaphorins in prostate cancer","volume":"71","author":"Williamson","year":"2011","journal-title":"Prostate"},{"key":"37","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1158\/0008-5472.CAN-11-3892","article-title":"Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer","volume":"72","author":"Luo","year":"2012","journal-title":"Cancer Res"},{"key":"38","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1073\/pnas.0810956106","article-title":"The role of PTEN\/Akt\/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations","volume":"106","author":"Reddy","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"39","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.stem.2010.11.013","article-title":"Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation","volume":"7","author":"Witte","year":"2010","journal-title":"Cell Stem Cell"},{"key":"40","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1172\/JCI57477","article-title":"Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer","volume":"122","author":"Sixma","year":"2012","journal-title":"J Clin Invest"},{"key":"41","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1111\/febs.13112","article-title":"The controversial role of the Polycomb group proteins in transcription and cancer: how much do we not understand Polycomb proteins?","volume":"282","author":"Pasini","year":"2015","journal-title":"FEBS J"},{"key":"42","article-title":"Perineural invasion and risk of lethal prostate cancer","author":"Fall","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"43","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/pros.23067","article-title":"Perineural invasion in prostate biopsy specimens is associated with increased bone metastasis in prostate cancer","volume":"75","author":"Dillioglugil","year":"2015","journal-title":"Prostate"},{"key":"44","doi-asserted-by":"crossref","first-page":"1236361","DOI":"10.1126\/science.1236361","article-title":"Autonomic nerve development contributes to prostate cancer progression","volume":"341","author":"Frenette","year":"2013","journal-title":"Science"},{"key":"45","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1158\/0008-5472.CAN-04-3448","article-title":"Human osteocalcin and bone sialoprotein mediating osteomimicry of prostate cancer cells: role of cAMP-dependent protein kinase A signaling pathway","volume":"65","author":"Chung","year":"2005","journal-title":"Cancer Res"},{"key":"46","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2741\/s110","article-title":"Osteomimicry: how tumor cells try to deceive the bone","volume":"2","author":"Teti","year":"2010","journal-title":"Front Biosci (Schol Ed)"},{"key":"47","doi-asserted-by":"crossref","first-page":"19359","DOI":"10.1074\/jbc.M113.477216","article-title":"Differential androgen deprivation therapies with anti-androgens casodex\/bicalutamide or MDV3100\/Enzalutamide versus anti-androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasis","volume":"288","author":"Chang","year":"2013","journal-title":"J Biol Chem"},{"key":"48","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ccr.2011.04.008","article-title":"Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer","volume":"19","author":"Sawyers","year":"2011","journal-title":"Cancer Cell"},{"key":"49","doi-asserted-by":"crossref","first-page":"e66855","DOI":"10.1371\/journal.pone.0066855","article-title":"Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy","volume":"8","author":"Ballman","year":"2013","journal-title":"PLoS One"},{"key":"50","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.eururo.2014.05.004","article-title":"A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling","volume":"66","author":"Tenggara-Hunter","year":"2014","journal-title":"Eur Urol"},{"key":"51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1476-4598-9-89","article-title":"Hedgehog\/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells","volume":"9","author":"Buttyan","year":"2010","journal-title":"Mol Cancer"},{"key":"52","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1158\/1078-0432.CCR-10-3077","article-title":"A novel HSP90 inhibitor delays castrate-resistant prostate cancer without altering serum PSA levels and inhibits osteoclastogenesis","volume":"17","author":"Zoubeidi","year":"2011","journal-title":"Clin Cancer Res"},{"key":"53","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.juro.2013.06.017","article-title":"Validation of a Genomic Classifier that Predicts Metastasis Following Radical Prostatectomy in an At Risk Patient Population","volume":"190","author":"Haddad","year":"2013","journal-title":"J Urology"},{"key":"54","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.eururo.2014.10.036","article-title":"A Genomic Classifier Improves Prediction of Metastatic Disease Within 5 Years After Surgery in Node-negative High-risk Prostate Cancer Patients Managed by Radical Prostatectomy Without Adjuvant Therapy","volume":"67","author":"Davicioni","year":"2015","journal-title":"European Urology"},{"key":"55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative Genomic Profiling of Human Prostate Cancer","volume":"18","author":"Landers","year":"2010","journal-title":"Cancer Cell"},{"key":"56","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1158\/0008-5472.CAN-05-3055","article-title":"Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells","volume":"66","author":"Moreno","year":"2006","journal-title":"Cancer Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:13:34Z","timestamp":1658535214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,27]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,3,21]]}},"alternative-id":["14850","28145883"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.14850","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,27]]}}}